Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PDE10A anticorps (AA 300-350)

PDE10A Reactivité: Humain, Rat, Souris, Singe WB, ELISA, IHC, IP, ICC, IF, CM Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN2747045
  • Antigène Voir toutes PDE10A Anticorps
    PDE10A (phosphodiesterase 10A (PDE10A))
    Épitope
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 300-350
    Reactivité
    • 25
    • 12
    • 8
    • 6
    • 1
    • 1
    • 1
    Humain, Rat, Souris, Singe
    Hôte
    • 19
    • 6
    Lapin
    Clonalité
    • 20
    • 5
    Polyclonal
    Conjugué
    • 15
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp PDE10A est non-conjugé
    Application
    • 17
    • 10
    • 7
    • 5
    • 5
    • 5
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC), Immunofluorescence (IF), Confocal Microscopy (CM)
    Purification
    Affinity Purified
    Immunogène
    Synthetic peptide taken within amino acid region 300-350 on human PDE10A2 protein common to all PDE10A variants.
    Isotype
    IgG
    Top Product
    Discover our top product PDE10A Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.7 μg/μL
  • Harada, Suzuki, Miura, Hasui, Kamiguchi, Ishii, Taniguchi, Kuroita, Takano, Stepanov, Halldin, Kimura: "Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A." dans: Nuclear medicine and biology, Vol. 42, Issue 2, pp. 146-54, (2015) (PubMed).

    Sancesario, Morrone, DAngelo, Castelli, Ferrazzoli, Sica, Martorana, Sorge, Cavaliere, Bernardi, Giorgi: "Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism?" dans: Neurochemistry international, Vol. 79, pp. 44-56, (2015) (PubMed).

    Mango, Bonito-Oliva, Ledonne, Nisticò, Castelli, Giorgi, Sancesario, Fisone, Berretta, Mercuri: "Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions." dans: Neuropharmacology, Vol. 76 Pt A, pp. 127-36, (2014) (PubMed).

    Heine, Sygnecka, Scherf, Berndt, Egerland, Hage, Franke: "Phosphodiesterase 2 inhibitors promote axonal outgrowth in organotypic slice co-cultures." dans: Neuro-Signals, Vol. 21, Issue 3-4, pp. 197-212, (2013) (PubMed).

    Giorgi, Melchiorri, Nuccetelli, DAngelo, Martorana, Sorge, Castelli, Bernardi, Sancesario: "PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology." dans: Neurobiology of disease, Vol. 43, Issue 1, pp. 293-303, (2011) (PubMed).

    Ong, Gribble, Reimann, Lynch, Houslay, Baillie, Furman, Pyne: "The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon-like peptide-1 release." dans: British journal of pharmacology, Vol. 157, Issue 4, pp. 633-44, (2009) (PubMed).

    Kruse, Møller, Tibaek, Gammeltoft, Olesen, Kruuse: "PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system." dans: Brain research, Vol. 1281, pp. 25-34, (2009) (PubMed).

    Bora, Gupta, Malik, Chachra, Sharma, Saini: "Development of a cell-based assay for screening of phosphodiesterase 10A (PDE10A) inhibitors using a stable recombinant HEK-293 cell line expressing high levels of PDE10A." dans: Biotechnology and applied biochemistry, Vol. 49, Issue Pt 2, pp. 129-34, (2008) (PubMed).

    Dlaboga, Hajjhussein, ODonnell: "Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum." dans: Neuropharmacology, Vol. 54, Issue 4, pp. 745-54, (2008) (PubMed).

    Albrecht, Uckert, Oelke, Andersson, Jonas, Tröger, Hedlund: "Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value?" dans: Journal of forensic and legal medicine, Vol. 14, Issue 5, pp. 270-4, (2007) (PubMed).

    Ückert, Oelke, Albrecht, Stief, Jonas, Hedlund: "Immunohistochemical description of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human labia minora." dans: The journal of sexual medicine, Vol. 4, Issue 3, pp. 602-608, (2007) (PubMed).

    Uckert, Oelke, Waldkirch, Stief, Albrecht, Tröger, Jonas, Andersson, Hedlund: "Cyclic adenosine monophosphate and cyclic guanosine monophosphate-phosphodiesterase isoenzymes in human vagina: relation to nitric oxide synthase isoforms and vasoactive intestinal polypeptide-containing nerves." dans: Urology, Vol. 65, Issue 3, pp. 604-10, (2005) (PubMed).

  • Antigène
    PDE10A (phosphodiesterase 10A (PDE10A))
    Autre désignation
    PDE10A (PDE10A Produits)
    Synonymes
    anticorps HSPDE10A, anticorps Pde10a3, anticorps phosphodiesterase 10A, anticorps PDE10A, anticorps Pde10a
    UniProt
    Q9Y233
    Pathways
    cAMP Metabolic Process
Vous êtes ici:
Support technique